[Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].

Source:http://linkedlifedata.com/resource/pubmed/id/14567168

Download in:

View as

General Info

PMID
14567168